Hormone Replacement Therapy After Risk-Reducing Surgery in Individuals at Increased Risk for Breast Cancer: The Patient Perspective
https://www.facingourrisk.org/research-clinical-trials/study/337/hrt-after-risk-reducing-surgery-in-women-at-increased-risk-for-breast-cancer-the-patient-perspective
Survey for individuals with a BRCA1, BRCA2, PALB2, RAD51C, RAD51D mutation
About the Study
NOTE: This study is no longer recruiting people.
In this study, we aim to better understand patient perceptions about hormone replacement therapy (HRT) and identify factors informing decision making about HRT for use in individuals who have a BRCA1, BRCA2, PALB2, RAD51C or RAD51D genetic mutation that increases breast and ovarian cancer risk.
Individuals who have undergone risk-reducing surgery for ovarian cancer will be asked to complete a survey about their thoughts, experiences and understanding of the risks and benefits related to hormone replacement therapy.
This Study is Open To:
NOTE: This study is no longer recruiting people.
This Study is Not Open To:
NOTE: This study is no longer recruiting people.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.